Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A.

Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A.

In mouse models of chronic inflammatory diseases, Natural Killer (NK) cells can play an immunoregulatory role by eliminating chronically activated leukocytes. Indirect evidence suggests that NK cells may also be immunoregulatory in humans. Two subsets of human NK cells can be phenotypically distingu...

Full description

Bibliographic Details
Main Authors:	Natasja Nielsen, Niels Ødum, Birgitte Ursø, Lewis L Lanier, Pieter Spee
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3284517?pdf=render

Similar Items

CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells.
by: Söderström, K, et al.
Published: (1997)

HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
by: King, A, et al.
Published: (2000)

BLOCKING THE INHIBITORY CD94/NKG2A NK CELL RECEPTOR WITH A NOVEL ANTI-NKG2A MAB ENHANCES THE SUSCEPTIBILITY OF RHEUMATOID ARTHRITIS FIBROBLAST-LIKE SYNOVIOCYTES (FLS) TO NK CELL-MEDIATED CYTOTOXICITY
by: Nielsen, N, et al.
Published: (2012)

Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia
by: Melanie Märklin, et al.
Published: (2019-05-01)

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
by: Braud, V, et al.
Published: (1998)

Distinctive CD56dim NK subset profiles and increased NKG2D expression in blood NK cells of Parkinson’s disease patients
by: Stephen Weber, et al.
Published: (2024-02-01)

Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E.
by: Braud, V, et al.
Published: (1999)

Targeting NKG2DL with Bispecific NKG2D–CD16 and NKG2D–CD3 Fusion Proteins on Triple–Negative Breast Cancer
by: Polina Kaidun, et al.
Published: (2023-08-01)

PECULIARITIES OF NK CELLS DIFFERENTIATION: CD56dim AND CD56bright NK CELLS AT PREGNANCY AND IN NON-PREGNANT STATE
by: V. A. Mikhailova, et al.
Published: (2017-01-01)

The role of CD56bright NK cells in neurodegenerative disorders
by: Carla Rodriguez-Mogeda, et al.
Published: (2024-02-01)

Elusive Role of the CD94/NKG2C NK Cell Receptor in the Response to Cytomegalovirus: Novel Experimental Observations in a Reporter Cell System
by: Aldi Pupuleku, et al.
Published: (2017-10-01)

High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation
by: Huisman, BD, et al.
Published: (2023)

High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation
by: Brooke D. Huisman, et al.
Published: (2023-08-01)

CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts.
by: Chan, A, et al.
Published: (2007)

A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.
by: Michaëlsson, J, et al.
Published: (2002)

Reduction of the CD16(-)CD56bright NK cell subset precedes NK cell dysfunction in prostate cancer.
by: Kyo Chul Koo, et al.
Published: (2013-01-01)

Enriched HLA-E and CD94/NKG2A interaction limits antitumor CD8+ tumor-infiltrating T lymphocyte responses
by: Abd Hamid, M, et al.
Published: (2019)

NKG2D+CD4+ T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus
by: Di Yang, et al.
Published: (2017-04-01)

Enriched HLA-E and CD94/NKG2a interaction limits anti-tumor CD8+ tumor-infiltrating T lymphocyte responses
by: Abd Hamid, M, et al.
Published: (2019)

Expression of NKG2D Receptors in CD3+ and CD56+ Cells in Blood Samples of Pre-eclampsia Patients and the Effect of Silymarin on Their Activity in Vitro
by: Ali Reza Andalib, et al.
Published: (2022-04-01)

Publisher Correction: High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation
by: Brooke D. Huisman, et al.
Published: (2023-08-01)

The tetraspanin CD53 modulates responses from activating NK cell receptors, promoting LFA-1 activation and dampening NK cell effector functions.
by: Izabela Todros-Dawda, et al.
Published: (2014-01-01)

Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells
by: Valentina Gentili, et al.
Published: (2023-07-01)

Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas
by: Ilona Hagelstein, et al.
Published: (2021-04-01)

Loss of CCR7 expression on CD56(bright) NK cells is associated with a CD56(dim)CD16⁺ NK cell-like phenotype and correlates with HIV viral load.
by: Henoch S Hong, et al.
Published: (2012-01-01)

Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.
by: Nielsen, N, et al.
Published: (2014)

Flow cytometric visualisation of cytokine production by CD3-CD56+ NK cells and CD3+CD56+ NK-T cells in whole blood.
by: Mendes, R, et al.
Published: (2000)

NKG7 Enhances CD8+ T Cell Synapse Efficiency to Limit Inflammation
by: Emily J. Lelliott, et al.
Published: (2022-07-01)

A role for NKG2D in NK cell-mediated resistance to poxvirus disease.
by: Min Fang, et al.
Published: (2008-02-01)

KIR+CD8+ and NKG2A+CD8+ T cells are distinct innate-like populations in humans
by: Seong Jin Choi, et al.
Published: (2023-03-01)

Regulation of development of CD56 bright CD11c + NK-like cells with helper function by IL-18.
by: Wen Li, et al.
Published: (2013-01-01)

502 Discovery of HX017, a novel NKG2A/CD94 mAb, for potential cancer immunotherapy
by: Faming Zhang, et al.
Published: (2023-11-01)

NKG2D⁺ IFN-γ⁺ CD8⁺ T cells are responsible for palladium allergy.
by: Mitsuko Kawano, et al.
Published: (2014-01-01)

NKG2D signaling certifies effector CD8 T cells for memory formation
by: Cynthia Perez, et al.
Published: (2019-02-01)

Functional dichotomy between NKG2D and CD28-mediated co-stimulation in human CD8+ T cells.
by: Kamalakannan Rajasekaran, et al.
Published: (2010-09-01)

Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/Ribavirin Therapy in Chronic Hepatitis C.
by: Po-sung Chu, et al.
Published: (2015-01-01)

Single-cell profiling reveals periventricular CD56bright NK cell accumulation in multiple sclerosis
by: Sabela Rodríguez-Lorenzo, et al.
Published: (2022-05-01)

Deep phenotyping characterization of human unconventional CD8+NKG2A/C+ T cells among T and NK cells by spectral flow cytometry
by: Aurelio Orta-Resendiz, et al.
Published: (2023-12-01)

NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme
by: Shafiq Murad, et al.
Published: (2022-05-01)

Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion.
by: de Matos, C, et al.
Published: (2007)